Metamifop-induced human breast cancer cells proliferation: Revealing a proliferation mechanism distinct from 17β-estradiol

Key Points

• Proliferation mechanism distinct from 17β-estradiol is activated by metamifop in human breast cancer cells.
• Key evidence shows over 50% increase in cell proliferation rates linked to metamifop application.
• Analysis of cell signaling pathways indicated altered hormonal response pathways distinct from typical estrogenic effects.
• Highlights the need for further exploration into metamifop's role in breast cancer growth and treatment strategies.